Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes

AIM: To evaluate the efficacy and safety of triple therapy with low‐dose dapagliflozin plus saxagliptin added to metformin in uncontrolled type 2 diabetes. MATERIALS AND METHODS: This 24‐week, double‐blind trial (NCT02681094) randomized 883 patients (glycated haemoglobin [HbA1c] 7.5‐10.0%) on metfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Perl, Shira, Johnsson, Eva, García‐Sánchez, Ricardo, Jacob, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771748/
https://www.ncbi.nlm.nih.gov/pubmed/31144431
http://dx.doi.org/10.1111/dom.13795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771748/
https://www.ncbi.nlm.nih.gov/pubmed/31144431
http://dx.doi.org/10.1111/dom.13795

Ejemplares similares